Research studies offer hope that we can one day end the devastation caused by dementia – and research is only possible thanks ...

Alzheimer’s Society funds high-quality research across all areas of dementia that are most relevant to people affected by the ...

A major clinical trial aiming to transform the diagnosis of Alzheimer’s disease through a simple blood test, is now welcoming ...

Turning Up the Volume is the largest-ever survey with people with dementia to hear their views and experiences of what daily life is like. Turning Up the Volume: unheard voices of people with dementia ...

Alzheimer’s Society is continuing work on the Blood Biomarker Challenge, a project that could bring dementia blood tests to the NHS within five years. Blood-based biomarkers could be the ...

In August 2024, lecanemab (marketed as Leqembi in the UK) was approved as a treatment for some people living with early Alzheimer’s disease. The drug can slow down the decline in memory and thinking ...

Finding out that someone close to you has dementia is difficult. Children and young people, who may not fully understand what dementia is or how to cope with their emotions, may need extra support.

Children and young people can help the person with dementia. While it won't always be appropriate for them to be involved, there are aspects of caring that are fulfilling. Explaining dementia to ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved donanemab (marketed as Kisunla in the UK) as a treatment for some people with early-stage Alzheimer’s disease. The drug can ...

Val Horncastle, who had Alzheimer’s disease, came up with the idea for the ‘Memory Calendar’ with her husband Keith. We hear how a calendar designed to help one person is benefiting many others. Val ...

Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, has called breakthrough Alzheimer's drug donanemab, 'a turning point', as the full trial results were revealed. Full results ...

Amyloid is a protein that is found in our brains and bodies, but in Alzheimer’s disease, amyloid sticks together and forms different sized clumps that later become plaques in the brain. Amyloid is ...